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Duplications Involving a Conserved Regulatory Element
Downstream of BMP2 Are Associated
with Brachydactyly Type A2
Katarina Dathe,1,10 Klaus W. Kjaer,2,10 Anja Brehm,1,3,4 Peter Meinecke,5 Peter Nu¨rnberg,6,7
Jordao C. Neto,8 Decio Brunoni,8 Nils Tommerup,2 Claus E. Ott,1 Eva Klopocki,1 Petra Seemann,3,9
and Stefan Mundlos1,3,9,*
Autosomal-dominant brachydactyly type A2 (BDA2), a limbmalformation characterized by hypoplastic middle phalanges of the second
and ﬁfth ﬁngers, has been shown to be due to mutations in the Bone morphogenetic protein receptor 1B (BMPR1B) or in its ligand
Growth and differentiation factor 5 (GDF5). A linkage analysis performed in a mutation-negative family identiﬁed a novel locus for
BDA2 on chromosome 20p12.3 that incorporates the gene for Bone morphogenetic protein 2 (BMP2). No point mutation was identiﬁed
in BMP2, so a high-density array CGH analysis covering the critical interval of ~1.3 Mb was performed. A microduplication of
~5.5 kb in a noncoding sequence ~110 kb downstream of BMP2 was detected. Screening of other patients by qPCR revealed a similar
duplication in a second family. The duplicated region contains evolutionary highly conserved sequences suggestive of a long-range regu-
lator. By using a transgenic mouse model we can show that this sequence is able to drive expression of a X-Gal reporter construct in the
limbs. The almost complete overlap with endogenous Bmp2 expression indicates that a limb-speciﬁc enhancer of Bmp2 is located within
the identiﬁed duplication. Our results reveal an additional functional mechanism for the pathogenesis of BDA2, which is duplication of
a regulatory element that affects the expression of BMP2 in the developing limb.Embryonic development depends on tight control of gene
expression. In many instances, regulatory promoters
located immediately upstream of the transcription start
site contain sufﬁcient information to direct correct gene
expression. In many developmentally important genes,
though, more complex regulatory mechanisms are needed
to drive dynamic spatially and temporally controlled
expression patterns. Such cis-regulatory elements can be
located upstream or downstream or within introns of the
transcription unit.1 They are frequently conserved among
species and may be located as far as 1.5 Mb in either direc-
tion. Several studies have identiﬁed such elements as
essential regulators of developmental gene expression,
that have the potential to switch genes off and on in partic-
ular types of cells/tissues during certain developmental
time points. Given the importance of gene regulation in
development, it is to be expected that a large number of
developmental defects is caused by mutations affecting
such regulatory elements (for review see 2). However,
because of the relative paucity of information regarding
the basic mechanisms of gene regulation, only a few
gene alterations affecting regulatory elements have been
reported so far. Here we describe a tandem duplication of
a ~5.5 kb element 30 of BMP2 (MIM *112261), which is
associated with brachydactyly type A2 (BDA2 [MIM
#112600]).The brachydactylies are a related group of conditions,
several of which are caused by mutations in genes that
are linked to the bone morphogenetic protein (BMP)
pathway. BMPs and the related growth and differentiation
factors (GDFs) are phylogenetically conserved signaling
proteins that belong to the transforming growth factor
beta (TGF-b) superfamily. Originally identiﬁed for their
ability to induce bone, they were subsequently shown to
be involved in multiple aspects of body patterning and
morphogenesis.3 BMPs initiate their signaling pathways
through binding to two types of transmembrane receptors,
the BMP type I and the type II receptor. Upon ligand
binding, the receptors dimerize and activate Smad tran-
scription factors that subsequently regulate gene expres-
sion in the nucleus. The activity of BMPs is regulated at
multiple levels including extracellular inhibitors such as
Noggin (MIM *602991). Mutations in components of this
pathway are known to result in various types of brachydac-
tylies (BDA2 [MIM #112600]; brachydactyly type C, BDC
[MIM #113100]; brachydactyly type B2, BDB2 [MIM
#611377]), symphalangism (SYM1 [MIM #185800]), and
multiple synostosis syndrome (SYNS1 [MIM #186500])
but are also associatedwithmore complex skeletal disorders
such as the acromesomelic chondrodysplasias (MIM
#200700, MIM #201250, MIM #228900) and ﬁbrodysplasia
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Figure 1. Pedigrees and Clinical Phenotype
(A) Pedigrees. Affected individuals are indicated by black symbols. Symbols with a þ indicate individuals who were clinically examined
and for whom further molecular analysis was performed.
(B) Clinical phenotype caused by the duplication. BDA2 with shortened and medially deviated second fingers caused by hypoplastic and
triangular middle phalanges was observed in almost all of the affected individuals as demonstrated in the photograph and X-rays of an
affected adult (*) and an 18-month-old affected child (***). One affected individual in family 1 (**) showed a more severe phenotype,
displaying considerable shortened and deviated second and third fingers resulting from hypoplastic and malformed proximal as well as
middle phalanges showing similarities to BDC.BDA2 refers to a genetically heterogeneous subset of
brachydactylies characterized by hypoplastic or aplastic
middle phalanges of the second and ﬁfth ﬁnger. So far,
dominant-negative mutations in the BMP-receptor
BMPR1B (MIM *603248) and a speciﬁc missense mutation
in GDF5 (MIM *601146) resulting in a loss of binding to
BMPR1B are known to cause isolated BDA2.5,6 In addition,
mutations that affect the GDF5 cleavage site were shown
to result in a similar phenotype.38 On the contrary,
mutations that lead to an activation of GDF5 or in a loss
of function (LOF) of its inhibitor NOGGIN result in fusion
of phalanges caused by a lack of joint formation.6,7
Thus, a loss of BMPR1B-mediated activity appears to be
associated with a hypoplasia of phalanges whereas
activation of the BMP pathway results in joint fusions
(symphalangism).484 The American Journal of Human Genetics 84, 483–492, April 10,In this article we describe a novel molecular basis for the
BDA2 phenotype in two unrelated families. The investi-
gated pedigrees are shown in Figure 1A. One of the pedi-
grees is part of a large Brazilian kindred of German origin
originally published as a clinical description in1980 (family
1).8 The smaller family is of European origin as well (family
2). Within the families, the phenotype appeared to be vari-
able but penetrance was complete. The phenotypes of
affectedhands are shown inFigure1B. In family1,we exam-
ined 21 affected and 5 unaffected individuals. Hand and
foot radiographs were obtained for 14 affected individuals.
The predominant trait was in accordance with BDA2, i.e.,
shortening of the second mesophalanx associated with
a medial deviation in the proximal interphalangeal joint
(PIP) andatypical or even absent phalangeal ﬂexion creases.
On radiographs, the second mesophalanx often appeared2009
triangular (Figure 1B, *). In addition, we observed ulnar
deviation and limited passive and active movement of the
PIP or distal interphalangeal joint (DIP) in the third, fourth,
and ﬁfth ﬁngers in some affected individuals. The lower
limb phenotype was generally milder with shortening of
the second toe deviating radially in the metatarsal-phalan-
geal joint, eventually combined with hallux valgus of the
big toe. In a single patient, the hands appeared normal,
and shortening of the second toe bilaterally was the only
observed pathology. The most severely affected individual
displayed short malformed third proximal phalanges and
mesophalanges, absent third and fourth DIP ﬂexion
creases, and a simian ﬂexion crease in addition to a severe
shortening and malformation of the second proximal
phalanx and mesophalanx (Figure 1B, **). This phenotype
has similarities to BDC. His feet showed hallux valgus and
a short triangular mesophalanx on the second toe bilater-
ally. In family 2, only the mother in generation II and her
child were investigated. Both presented with characteristic
BDA2 (Figure 1B, ***).
We obtained blood samples or buccal swabs from the
family members indicated in the pedigrees and extracted
DNA by standard methods. Selected affected individuals
of the families described here were screened for mutations
in BMPR1B, GDF5, as well as in other genes known to be
associated with BD phenotypes such as IHH (MIM
*600726), ROR2 (MIM *602337), and HOXD13 (MIM
*142989), but no mutation was detected. All sequencing
experiments were carried out by standard techniques as re-
ported elsewhere.5,9–12 All participants gave their consent
for molecular testing. The study was approved by the local
ethics committee.
The molecular basis for BDA2 was unclear in family 1, so
we genotyped DNA samples from 10 individuals of the
family with the Affymetrix GeneChip Human Mapping
10KArray, version2.0 (Affymetrix, SantaClara,CA)andper-
formed a genome-wide linkage analysis. Genotypes were
called by the GeneChip DNA Analysis Software (GDAS
v2.0; Affymetrix). Relationship errors were evaluated with
thehelp of the programGraphical Relationship Representa-
tion (GRR).13 The program PedCheck was applied to detect
Mendelian errors14 and data for SNPs with such errors were
removed from the data set. Non-Mendelian errors were
identiﬁed with the program MERLIN15 and unlikely geno-
types for related samples were deleted. Parametric linkage
analysis was performed with a modiﬁed version of the
programGENEHUNTER 2.1.16,17We used a sliding window
with sets of 90 SNPs for calculation assuming autosomal-
dominant inheritance with full penetrance and a disease
allele frequency of 0.0001. Haplotypes were reconstructed
with MERLIN and displayed graphically with Haplo-
Painter.18 All data handling was performed with the graph-
ical user interface ALOHOMORA.19
As a result, a further locus for brachydactyly was mapped
to a ~30 cM region between the telomer and marker
rs953021 on chromosome 20p12.3 (lod score 3.31). Micro-
satellite markers were used for further ﬁne mappingThe Amincluding all collected DNA samples. Because of an addi-
tional recombination in another family member, the crit-
ical region was narrowed down to a ~1.3 Mb region
between 5.68 and 7.01 Mb on chromosome 20 (positions
according UCSC Human Genome July 2003). Searching
for candidate genes in this interval, we ﬁrst focused on
BMP2, which is located at 6.696–6.708 Mb because a dereg-
ulation of BMP signaling is known to play a key role in the
pathogenesis of BD. Sequencing of all exons, introns, 30
UTR, and 50 UTR as well as evolutionary highly conserved
regions in the direct 30 and 50 ﬂanking sequences of BMP2
revealed no mutation. Next, the coding regions of all
annotated genes and transcripts lying in the conﬁned
interval were sequenced but no mutation was detected.
BMP2 is embedded in a ‘‘gene desert,’’ based on the lack of
annotated genes ~600 kb upstream and ~1.1 Mb down-
stream of BMP2. Large gene deserts containing conserved
sequences ﬂanking developmental genes such as BMP2
argue for the possibility of noncoding regulatory elements,
which canbe locatedhundreds of kb away of the gene itself.
In other genes, e.g., SHH (MIM *600725), SHOX (MIM
*312865), PAX6 (MIM *607108), or SOX9 (MIM *608160),
it was already shown that such elements are involved in
the regulation of tissue-speciﬁc gene expression and also
control target gene expression in deﬁned temporal
processes during embryonic development.2,20–23 Because
genomic aberrations are a possible cause of hand and foot
malformations,21,22 we subsequently performed array-
based comparative genomic hybridization (array CGH)
analysis to screen for submicroscopic chromosomal aberra-
tions in the family 1mapped to 20p12.3. Previous karyotyp-
ing of GTG-banded chromosomes from lymphocytes in an
affected family member did not reveal any chromosomal
abnormalities. To assess imbalances at the BMP2 locus, we
designed a custom array (Roche NimbleGen Inc., Madison
WI) for array CGH analysis that covers the critical region
between 5.68 Mb and 7.01 Mb on human chromosome 20
at high density (average probe spacing 8 bp). Array CGH
analysis was performed as a service at Roche NimbleGen,
Iceland, according tomanufacturer’s protocol. In brief, 2 mg
of genomicDNAwere sonicated, yielding500–2000bp frag-
ments. After ﬂuorescent labeling, the test and reference
DNA were hybridized for 15 to 20 hr on a MAUI Station.
The array was washed and consecutively scanned on
a GenePix 4000B scanner (Axon Instruments). Scanned
images were analyzed with the NimbleScan software.
Circular binary segmentation algorithm24 was employed
for aberrationdetection. The genomicproﬁlewas visualized
by the SignalMap software (SignalMap v1.9.0.03, Nimble-
Gen Systems Inc.). With this custom array, a small duplica-
tion of about 5.5 kb ranging from approximately 6,808,500
to6,814,000bpwas identiﬁed in an affected familymember
(Figure 2A). The duplication is located ~110 kb downstream
of BMP2 in a noncoding sequence.
With quantitative real-time PCR (qPCR), the duplication
was conﬁrmed in 4 affected individuals of pedigree 1 and
excluded in 4 unaffected members of the familyerican Journal of Human Genetics 84, 483–492, April 10, 2009 485
Figure 2. Microduplication on 20p12.3
(A) Genomic profile of the microduplication as detected on NimbleGen custom array. The detected breakpoints are indicated by arrows.
The duplication comprises ~5.5 kb. The gray horizontal lines indicate the segments as calculated by the CBS algorithm with 50 bp segmen-
tation. x axis shows genomic positions on chromosome 20; y axis shows log2ratio.
(B) Microduplication confirmed by quantitative real-time PCR. The mean values for relative quantification were exported from the 7900
SDS software. For 4 affected (dark gray bars) and 4 nonaffected (light gray bars) individuals, mean values and standard deviations (error
bars) for each target amplicon relative to Albumin as a two-copy reference gene were calculated. For gender determination, mean values
and SDs for factor VIII on the X chromosome were calculated relative to Albumin as an autosomal two-copy reference gene. Results were
calibrated to the mean value determined for a healthy female control. P1–P5 refers to primers shown in Table S1. One duplicated allele
plus one normal allele results in three copies for the amplicons of primer pairs P2, P3, and P4 within the duplicated region in the affected
individuals and therefore in a ratio of 1.5 relative to the two copies of the healthy female control. Localization of qPCR amplicons is
illustrated in Figure 3C.(Figure 2B). The dark gray bars in Figure 2B show the mean
value of the investigated affected individuals and the light
gray bars the mean value of unaffected individuals. The
mean values for relative quantiﬁcation were exported
from the 7900 SDS software. Five primer pairs covered
the respective proximal and distal breakpoint regions,
with three primer pairs within the duplicated region and
two within the ﬂanking sequences as proposed by the
custom array results. Primer sequences are given in Table
S1 available online and genomic positions are illustrated
in Figure 3C. With a qPCR and breakpoint-PCR screening,
the microduplication was not detected in more than
200 DNA samples of clinically asymptomatic control indi-
viduals excluding a common copy number variant (CNV)
(data not shown). The qPCR experiments were performed
as described previously.21
Analysis by PCR with primers P6-forward and P6-reverse
(Table S1; Figure 3C) on genomic DNA level allowed the486 The American Journal of Human Genetics 84, 483–492, April 10identiﬁcationof a junction fragment that included the tran-
sition site between the telomeric and centromeric break-
points in all affected family members’ DNA of pedigree 1
(Figures 3A and 3B). This fragment of 867 bp was undetect-
able in nonaffected blood relatives as well as in the in-laws
of the family (data not shown), showing cosegregation of
the aberration with the BDA2 phenotype. By the following
direct sequencing of this fragment, we were able to identify
a microhomology of seven nucleotides GTGAACC begin-
ning at the telomeric position 6,808,129 bp and at the
centromeric side on position 6,814,024 bp (positions ac-
cording to UCSC Human Genome March 2006). Thus, the
twobreakpoints are apparently locatedwithin themicroho-
mology of seven nucleotide on either side. Based on these
ﬁndings, we conclude that the fragment was duplicated in
tandem and had a size of 5,895 bp (Figure 3C).
Furthermore, we performed a screening of 22 unrelated
affected individuals with well-characterized BDA2 or BDC, 2009
Figure 3. Breakpoint Identification by Sequence Analysis
(A) Sequence analysis of the junction fragment revealed a tandem duplication of 5,895 bp in family 1 and a tandem duplication of
5,547 bp in family 2. The top line on the left displays the centromeric reference sequence (ref. seq.). Below are the electropherograms
of one affected individual of each family. The centromeric breakpoint is identical in both families. Note the differences in the telomeric
sequence after the seven homologous nucleotides (surrounded by the blue box) of the junction fragment between the two families. The
breakpoints are located within this homologous sequence or at the adjacent nucleotides.
(B) PCR products obtained with primers P6-forward and P6-reverse result in an 867 bp fragment in family 1 and in a 519 bp fragment in
family 2.
(C) Illustration of qPCR amplicons and sequencing primer positions as well as localization of the duplicated regions and breakpoints in
family 1 and 2 on chromosome 20.phenotypes without mutations in the so far known bra-
chydactyly genes with qPCR with all ﬁve primer pairs
mentioned above. With this approach, a similar duplica-
tion was identiﬁed in one affected mother and her affected
daughter (family 2) (Figures 3A and 3B). Breakpoint anal-
ysis in these individuals revealed an identical centromeric
breakpoint region as detected in family 1 but a different te-
lomeric breakpoint region subsequently located between
6,808,476 and 6,808,477 bp or within the following seven
nucleotides (positions according to UCSCHumanGenome
March 2006), resulting in a slightly smaller tandem dupli-
cation of 5,547 bp (Figure 3C). DNA samples of the remain-
ing 21 patients were also screened for single nucleotide
changes in the conserved elements of the duplicated
region but no pathogenic alterations were detected. Point
mutations in the coding sequence of BMP2 were also
excluded in these patients.The AmAs conceivable mechanisms that lead to the identiﬁed
genomic duplications, different possibilities have to be
considered. The telomeric breakpoints in both families as
well as the common centromeric breakpoint are located
within regions of short interspersed elements (SINEs) of
the Alu gene family. Because of their repetitive sequence,
Alu elements can mediate unequal homologous recombi-
nation that is estimated to be the underlying mechanism
for approximately 0.3% of all human genetic diseases.25
In addition, the breakpoints described here are located
within a 7 nucleotide microhomology sequence that
contains a recognition sequence (50-GTT-30) for topoiso-
merase I. Thus, nonallelic homologous recombination
mediated by topoisomerases has to be considered as an
alternative mechanism.26 For illegitimate recombination,
microhomology of two to six nucleotides is necessary after
the cleavage site. In our case, the cleavage site is followederican Journal of Human Genetics 84, 483–492, April 10, 2009 487
Figure 4. Schematic Representation of the Critical Region on 20p12.3
BMP2 and the 30 distant duplicated region containing a limb-specific regulatory element that lies about 110 kb downstream of the gene
itself are shown. The duplicated region (gray box) in family 1 described here starts at nucleotide 6,808,129 bp and ends at nucleotide
6,814,024 bp on chromosome 20. In family 2, the duplication starts at nucleotide 6,808,477 bp and ends similar as in family 1 at nucle-
otide 6,808,024 bp (positions according to UCSC Human Genome March 2006). The conservation of the duplicated sequence in different
species is depicted in the UCSC genome browser plot. Within the sequence here are two highly conserved regions between mammals and
chicken. The positions of the homologous mouse sequence on chromosome 2 are shown under the alignments ranging from 133,355,678
to 133,360,193 bp (UCSC Mouse Genome February 2006). This sequence was cloned into the mBmp2-h-ER_pSfi-Hsp promoter X-Gal trans-
gene construct.by the three nucleotides 50-CAC-30 (note that Figure 3A
shows the sequences in reverse orientation; recognition
sequence in underlined, i.e., 30-GTGAACC-50). A replica-
tion-based model called fork stalling and template switch-
ing (FoSTeS) described by Lee et al. should also be taken
into consideration.27 The hypothesis states that during
the DNA replication process the replication fork can stall
at DNA regions of genomic instability, e.g., at repetitive
sequences, leading as a consequence to a switch of the
lagging strand to another active replication fork in phys-
ical proximity. Microhomology between some base pairs,
as identiﬁed in the breakpoints described here, is sufﬁcient
for that template switching. Thus, the DNA sequence can
be replicated once again, which results in a duplication.
We identiﬁed two blocks of highly conserved noncoding
sequences within the duplication (Figure 4). It is known
that regulatory elements are located with highly conserved
regions, so we hypothesized that the microduplication
contains a potential regulator for Bmp2. To test this
hypothesis, we investigated the effect of the duplicated
WT region in a transgenic mouse model. According to
the smaller duplication in family 2, the homologous
mouse sequence on chromosome 2 was identiﬁed to range
from 133,355,678 to 133,360,193 bp (UCSC Mouse
Genome, February 2006), comprising 4,515 bp (Figure 4).
This region was cloned with the mouse BAC clone RP24-
82A15 obtained from Children’s Hospital Oakland
Research Institute. The following primers containing
NotI restriction sites (/) were used: forward gactgcggccgc/
GCCATGGCATTAATCAGACA and reverse gactgcggccgc/
TTCAGCACACCGTGCTTATC. This fragment is subse-
quently called mouse Bmp2 homolog-enhancer region488 The American Journal of Human Genetics 84, 483–492, April 10(mBmp2-h-ER). mBmp2-h-ER was ligated into pSﬁ-
Hsp68lacZ (a kind gift of Douglas P. Mortlock) in forward
orientation.20,23,28 The mBmp2-h-ER_pSﬁ-Hsp promoter
X-Gal transgene construct was veriﬁed by direct
sequencing. For the generation of a transgenic mouse
model, the mBmp2-h-ER_pSﬁ-Hsp X-Gal plasmid was
used for pronuclear injection of C57BL6 embryos. Plasmid
DNA was linearized with SalI and further puriﬁed by gele-
lectrophoresis with the omni pure kit from Omni life
science (Hamburg, Germany). Pronuclear injections and
oviduct transfers were approved by the competent local
authority (LAGeSo) and performed according to standard
protocols. Transgenic embryos were created, collected at
E11.5–E14.5, and subjected to whole-mount X-Gal stain-
ing as previously described.29 The retained yolk sacs were
used for genotyping. These analyses revealed a speciﬁc
X-Gal staining in the limb buds and the developing
phalanges but not in other parts of the embryos (Figures
5A and 5B).
To compare the transgene expression pattern to the
typical expression pattern for Bmp2 and other genes
known to play an important role in the pathogenesis of
BDA2 and BDC, additional in situ hybridizations on WT
mouse embryos were performed for Bmp2, Gdf5, and the
receptors Bmpr1a and Bmpr1b on limb stages E11.5 to
E14.5. Whole-mount in situ hybridization was performed
as previously described with minor modiﬁcations.30–32
The results show that the endogenous expression of
Bmp2 in the limb is very similar to the X-Gal expression
of the transgene. Other sites of staining observed for
Bmp2 such as the whiskers, the somites, and the kidneys28
were not seen in X-Gal-stained embryos, indicating that, 2009
Figure 5. Expression Profiles of X-Gal in Transgenic Mice Compared to Bmp2, Gdf5, and Their Type I Receptors
(A) X-Gal staining of transgenic mice carrying the BDA2-associated duplicated region (mBmp2-h-ER). Left panel shows the entire embryo,
right panel magnification of fore limb. Developmental stage is given on right side. The number of embryos with specific X-gal staining in
the limbs out of the total number of transgene-positive embryos is shown in the right lower corner. Note that staining is present exclu-
sively in the limb autopod. At E11.5, X-Gal staining is present in a distinct region of the distal autopod. Coincidental with the formation
of the digit anlagen (E12.5), the staining moves toward the interdigital space. At E13.5 and E14.5, staining becomes restricted to the
distal interphalangeal joint region.
(B) Whole-mount in situ hybridization of Bmp2, Gdf5, and their receptors Bmpr1a and Bmpr1b. Note overlapping but not identical stain-
ing pattern between Bmp2 and X-Gal. Gdf5 expression marks the developing joints. Bmpr1a is expressed ubiquitously throughout the limb,
whereas Bmpr1b is restricted to the digit anlagen and the interphalangeal joints.mBmp2-h-ER drives expression exclusively in the limbs. At
E11.5, Bmp2 is known to be expressed in the apical ecto-
dermal ridge (AER), the underlying mesenchyme, and at
the posterior side of the limb. The latter domain, as well
as the AER expression, was not seen in the X-Gal-stained
animals. At E12.5, expression was located mainly between
the newly formed digits as well as in an area corresponding
to the posterior side of thewrist-forming region, in thewrist
itself, and in thedistal joints of radius andulna.At this stage,
X-Gal staining was also present in the interdigital mesen-
chyme but not in the more proximal domains. At E13.5,
Bmp2expressionwasconﬁnedtoa layerof cells surrounding
thecartilage condensationand thedorsal tendons.At E14.5,
Bmp2 expressionwas foundmainly around the joint regions
of the middle and proximal phalanges. X-Gal staining was
very similar at these stages ﬂanking the joint regions of
the distal interphalangeal joints.
Our results suggest that Bmp2 expression in the limb is
regulated by a 30 distant cis-acting enhancer that is located
within the duplication. Chandler and colleagues reported
that a BAC spanning the duplicated enhancer is able to
drive expression in the limb digits, whereas a BAC with
a deletion of this region showed no digit expression.The AmFurthermore, they identiﬁed two highly conserved
regions, named ECR-1 and ECR-2, located about þ156 kb
and þ160 kb 30 from Bmp2. One of these elements, ECR-1,
was shown to function as distant enhancers regulating
Bmp2 expression in differentiating osteoblasts.28 It is to
be expected that multiple other regulatory elements are
present in the vicinity of Bmp2 that regulate expression
in various tissues and stages of development.
Proteins of the BMP family are secreted signaling mole-
cules that are involved in numerous developmental
processes including patterning and organ development.
The role of Bmp2 during embryogenesis has been investi-
gated in detail before. It was shown that Bmp2 is expressed
in several embryonic regions, e.g., the kidneys, hair follicles,
tooth buds, and the gut epithelium. In addition, it is ex-
pressed in hypertrophic chondrocytes of the growth plate,
in the osteogenic perichondrium, and in osteoblasts.33–35
During development of the interphalangeal joints, Bmp2 is
ﬁrst expressed in a region surrounding the future joints. At
E14.5,Bmp2 expression is also found in the joint interzone.6
Functional studies of speciﬁcmutations resulting inBDA2
or BDC indicate that both phenotypes are the result of
a deregulation within the BMP pathway that alters theerican Journal of Human Genetics 84, 483–492, April 10, 2009 489
equilibrium between the ligand GDF5 and the BMP type 1
receptors leading to a decreased GDF5-BMPR1B
signaling.5,6,36,37 The brachydactyly phenotype in the fami-
lies described here is similar to the phenotype caused by
mutations in GDF5 or BMPR1B, so we hypothesize that the
identiﬁed duplication of the BMP2 enhancer region disturbs
the functional balance of BMPR1B signaling in a similar
manner.Differentmechanismshave tobe taken intoconsid-
eration for how this pathogenic effect could take place.
One possible explanation for the phenotype is a misex-
pression of BMP2. For example, an inversion involving
Shh was shown to result in ectopic expression of Shh in
the digits producing a BDA-like phenotype in mice.38
Duplication of the ZRS, a distant locus control region regu-
lating the expression of Shh in the limb, results in preaxial
polydactyly and syndactyly.21 The same phenotype can be
caused by point mutations in the ZRS.39 Interestingly,
similar mutations have been described in mice and cats
with polydactyly and these mutations were shown to
result in ectopic expression of Shh at the anterior margin
of the limb bud.40,41 Based on the assumption that similar
phenotypes are caused by similar pathogenetic mecha-
nisms, the ZRS duplication reported by Klopocki and
colleagues is thus likely to result in Shh misexpression.21
In analogy, the duplication described heremay lead tomis-
expression of Bmp2 and thus a deregulation of BMP
signaling during digit development.
Theoretically, the tandem duplication of a single regula-
tory element could impair its normal function by posi-
tional effects resulting in decreased BMP2 expression.
However, conditional ablation of Bmp2 in the mouse
limb did not cause any limb phenotype, showing that, at
least in the mouse, loss of Bmp2 is dispensable for limb
formation.42 A partial downregulation by this heterozy-
gous mutation is thus unlikely to have an effect. A more
likely scenario is an increase in BMP2 expression. Two
patients with large duplication of chromosome 20 encom-
passing BMP2 and the duplicated regulator sequence
described here were reported to have a BDA2 phenotype
in association with other malformations.43,44 It is to be
expected that a duplication of the entire BMP2 gene
including the regulatory regions results in an increase in
BMP2 expression. Assuming that the isolated BDA2 pheno-
type is caused by the same mechanism, a positional effect
of the duplication reported here seems thus unlikely. Thus,
the duplication most likely results in an increase in expres-
sion which, in contrast to the chromosomal duplications,
is restricted to the developing limb.
As shown in previous studies, BMP signaling appears to
be extremely dosage dependent, in particular during devel-
opment of the phalanges and their joints. In contrast to
Gdf5, which signals primarily through its high-afﬁnity
receptor BMPR1B, Bmp2 binds with high afﬁnity to
BMPR1A and BMPR1B.45 Too much Bmp2 would thus
result in a deregulation of the ﬁne-tuned BMP pathway
by increasing the BMPR1A signal and, consequently, in
a relative decrease of BMPR1B signaling. Furthermore, it490 The American Journal of Human Genetics 84, 483–492, April 10is conceivable that BMP2 interferes with the binding of
GDF5 to BMPR1B because of a competitive effect between
the two ligands, further shifting the equilibrium of BMP
type 1 receptor signaling toward BMPR1A. Such a reduction
in BMPR1B signaling is compatible with the previously
proposed molecular pathology of BDA2.
In summary, we demonstrate that a 5.5 kb tandem dupli-
cation downstream of BMP2 is associated with BDA2. The
duplication contains highly conserved sequences that are
likely to function as a cis-regulatory element regulating
BMP2 expression in the limb. Duplications of regulatory
elements can be considered as a mutational mechanism
for developmental defects.
Supplemental Data
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